US approves cheap version of HIV prevention shot
The US Food and Drug Administration on Monday approved a low-cost version of a twice-yearly HIV prevention shot, bringing the breakthrough drug closer to market in low-income countries. Read More: https://punchng.com/us-approves-cheap-version-of-hiv-prevention-shot/
The US Food and Drug Administration has approved a generic version of lenacapavir, an injectable HIV prevention medicine administered once every six months. This approval, which Punch Nigeria notes occurred on Monday, is expected to bring the drug closer to markets in low-income countries.
STAT News reports that the FDA gave tentative approval to Dr. Reddy’s Laboratories to manufacture the generic version, with plans to begin shipping the medicine next month. The generic drug is intended to increase access in dozens of low- and middle-income countries. According to STAT News, the annual cost per person will be $40, a price comparable to daily tablets.
The brand-name version of the drug, marketed by Gilead Sciences as Yetzugo, was approved by the FDA last year. STAT News describes lenacapavir as a tool that offers virtually complete protection against contracting HIV with a single administration every six months.
Brief written by urgent.news from Punch Nigeria, STAT News, IOL — 3 reports on this story. Machine-written — may contain errors; check the original before relying on it.
Also reported by 1 other outlet
- US approves cheap version of HIV prevention shot punchng.com
